1. Introduction {#sec1}
===============

The concept of "frail patient" is increasingly used in the clinical practice, without referring to an organic lesion, or to a specific diagnosis, but within the integral vision of the patient.

What has motivated the need to integrate this notion into clinical practice is the aging of the population. Data from the Spanish National Institute of Statistics show that from 1991 to 2001 in Spain the number of people over 85 years has almost doubled, from 449,773 in 1991 to 708,248 in 2001. In the last census in 2011, 1,113,247 people aged over 85 resided in Spain.

Labelling a patient as "frail" may be useful in assessing prognosis, deciding on a therapeutic approach, and planning health resources.

In the field of nephrology the association of chronic kidney disease and senile disease is practically indivisible. The introduction of the renal replacement techniques has undergone changes in its application to the elderly. If elderly patients were not routinely included in the hemodialysis program until the early 1980s \[[@B1]\], there is currently an increase in the age of incident and prevalent patients on hemodialysis. Data from the Registry of Renal Patients of Catalonia \[[@B2]\] confirm that 20% of patients who started hemodialysis in 2014 were older than 80 years. In addition, it is known that in this population the life expectancy after initiating dialysis is of 16 months for patients with an age between 80 and 84 years and 12 months for those of age of 85--89 years.

With a population whose age is clearly increasing, the notion of "frail patient" in hemodialysis is a necessary and essential emerging concept for better clinical care.

There is no consensus on the criteria that should be used to define frailty in patients on dialysis. There are some published papers \[[@B4]--[@B6]\] that investigate the frailty in dialysis and they mainly use criteria derived from the Fried frailty phenotype model, without considering characteristics of renal disease and dialysis.

Therefore, the aim of the present study is to define a frailty pattern among our dialysis population, to analyse the incidence and clinical evolution of these patients.

2. Materials and Methods {#sec2}
========================

This is a retrospective cross-sectional observational study. Individuals included in the study are patients with stage V chronic kidney disease who were on hemodialysis at 3 Diaverum dialysis centres (Barcelonès Nord and Maresme area) between September 2014 and September 2015. A total of 320 patients were analysed. All the patients approached for the study were enrolled.

Demographic, clinical, and analytical data were collected by reviewing the medical history. We reviewed the hospital admission rate during 1 year.

Data have been collected regarding the walking ability and ability to perform transfers, daily physical activity, and the possibility of performing the basic activities of daily living. The Charlson index and the Karnofsky scale have been calculated.

The Fried phenotype scale was applied to all patients \[[@B7]\].

Frailty was assed using the Fried frailty phenotype scale, the standard definition published by Fried \[[@B7]\] and colleagues in 2001 using data from the Cardiovascular Health Study. Frailty was defined as a clinical syndrome in which three or more of the following criteria were present: unintentional weight loss (10 lbs in past year), self-reported exhaustion, weakness (grip strength), slow walking speed, and low physical activity.

The frail patient on hemodialysis was defined by us with the Fried phenotype scale to which we added as new criteria that they performed more than 12 hours of hemodialysis per week. The current dialysis guidelines \[[@B8]\], DKIQO, recommend 3 dialysis sessions a week of 4 hours with the possibility of increasing dialysis time in special situations such as poor blood pressure control, severe alteration of bone mineral metabolism, and poor tolerance to dialysis, as maintained hypotension during the session that may lead to hyperhydration of patients.

2.1. Statistical Analysis {#sec2.1}
-------------------------

Descriptive statistics were used for all demographic and clinical data. Baseline characteristics were compared between frail and nonfrail patients. Continuous variables and categorical nominal variables with normal distribution were analysed using Student\'s *t*-test, the Mann--Whitney *U* test, or the Chi-square test, respectively. The normal distribution was assessed using the Kolmogorov-Smirnov test. The level of statistical significance was set at 0.05. All analyses were performed using statistical software for the social sciences (SPSS) version 20.

Logistic regression models were used to assess the association of the mortality with the clinical features and comorbidities.

3. Results {#sec3}
==========

3.1. Clinical and Laboratory Data of the Entire Population Included in the Study {#sec3.1}
--------------------------------------------------------------------------------

Clinical data are summarized in [Table 1](#tab1){ref-type="table"}.

Regarding the vascular access, 74.4% of the patients were dialysed through a native arteriovenous fistula, 5.3% through a prosthetic fistula, and the remaining 20.3% through a catheter.

3.2. Frail Patient {#sec3.2}
------------------

Using our frailty criteria 5.6% of the patients included in the study were frail.

Using the standard Fried frail phenotype definition 39,06% of our patients met criteria of frailty.

From the total of 320 patients included in the study 20 of them were receiving more than 12 hours of hemodialysis.

We have compared the clinical, analytical, and morbimortality characteristics among frail and nonfrail patients.

Statistically significant differences were found in BMI, hemoglobin (Hgb), and serum albumin between the two groups ([Table 2](#tab2){ref-type="table"}).

As for the associated comorbidities, statistically significant differences were found in the presence of peripheral vasculopathy (*p* = 0.004), cerebrovascular disease (*p* = 0.0079), and depression (*p* = 0.004) between the groups ([Table 3](#tab3){ref-type="table"}).

Statistically significant differences were found in the ability to perform basic activities of daily living (*p* \< 0.005) and transfers (*p* \< 0.005) and Karnofsky scale (*p* \< 0.005) ([Table 3](#tab3){ref-type="table"}).

When analysing vascular access, we detected a higher prevalence of catheter as vascular access in a group of patients defined as frail ([Table 4](#tab4){ref-type="table"}).

We found statistically significant differences between the two groups in terms of hospital admissions (0.77727 admissions/year of frail patients versus 0.2838 admissions per year of nonfrail patients *p* = 0.005). Mortality in the group of frail patients was 20.45%, while in nonfrail patients it was 12.36% (*p* \< 0.005).

We analysed the other clinical factors and comorbidities that might be related to hospitalization in our patients.

According to the multivariate analysis in addition to frailty, hospitalization has been associated with diabetes (*p* = 0.035) and peripheral vasculopathy (*p* = 0,018).

4. Discussion {#sec4}
=============

In our study, we identified only a 5.6% of the population that fulfilled our frailty criteria: the Fried phenotype definition of frailty widely used in clinical practice, in addition to the increase of more than 12 hours a week of hemodialysis, a criterion also widely used by nephrologists in this type of patients.

The heterogeneity of the concept makes it difficult to estimate its prevalence. Thus, in a review of the recent nephrological literature \[[@B9]\], it is emphasized that the prevalence of frailty among patients affected by CKD can vary from 4 to 59%, depending on the definition applied.

At present, there is no standard definition used for the "frail patient." In a systematic review of the Cochrane literature \[[@B10]\], the most frequently cited definition is Fried frailty phenotype criteria \[[@B7]\] that defines frailty as a clinical syndrome.

In individuals with CKD the prevalence of frailty increases as renal function declines \[[@B11]\].

In a systematic review aimed to assess frailty prevalence in CKD population, it was highlighted that more than one-third of end stage renal disease patients were frail based on objectively measured Cardiovascular Health Study criteria \[[@B12]\].

We think that the low percentage obtained in our population is due to the strict criteria used (3 or more criteria of the Fried frailty phenotype scale and more than 12 hours a week of hemodialysis). When applying only Fried phenotype scale alone the prevalence of frailty in our population is 39,06%, similar to previously published studies. We believe that it is important to take into account in addition to the phenotypic characteristics criteria related to the dialysis technique when defining a patient as frail. The need for increased dialysis time marks a poor clinical condition and adding this specification when defining a patients as frail may be useful to identify a narrower group of patients requiring increased medical attention.

In our study, age is not related to frailty, indicating that in patients with advanced chronic kidney disease there are other mechanisms involved in the concept of frailty, an aspect that has already been postulated in other studies \[[@B13]\].

The frail patient identified in our study is characterized by a BMI below 25 kg/m2, with a decrease in the ability to perform basic activities of daily living, with a decrease in the ability to ambulate and transfer, and with cerebrovascular disease and associated depression, which has decreased hemoglobin and serum albumin in blood analysis.

Efforts have been made to define the risk factors and mortality associated with dialysis \[[@B14]\]; previous studies have identified diabetes and vascular disease as predictors of mortality \[[@B15], [@B16]\]. Similarly, our frail patients present vascular disease, and, curiously, cerebrovascular disease and dementia.

Similar results among frail patients in dialysis were published. Frailty among hemodialysis patients is associated with peripheric vasculopathy, cardiac conditions, and low serum albumin \[[@B17]\].

Frail patients in dialysis are more likely to have poor cognitive function at the time of hemodialysis and initiation and worse global cognitive function 1 year after initiation \[[@B18]\].

The association of depression and cerebrovascular disease is known and may be due to a variety of mechanisms including stimulation of the sympathetic nervous system and also involving immune/inflammatory dysfunction. Depressive patients also have poorer health behaviours and depression is more frequent in hypertensive and diabetic patients. Previous papers had shown that patients with depression have an increased cardiovascular risk and an increased risk of morbidity and mortality in the event of a cardiovascular event \[[@B19], [@B20]\]. The coexistence of depression and frailty is greater than 10%; the presence of depression is being considered a risk factor of frailty \[[@B21]\].

Another remarkable fact in our study is that frail patients significantly use more catheters to perform dialysis sessions. In frail patients, the arteriovenous fistula is often more complicated due to atherosclerosis and/or morbidity that accompanies these patients, justifying this high percentage of catheters in this population. Our results are in agreement with the findings of the literature: catheter use is associated with increased inflammation and therefore mortality in the hemodialysis patient \[[@B22], [@B23]\].

A common observation is the interaction between the concepts of frailty, dependence, and disability \[[@B24], [@B25]\]; the emergence of frailty conditions involves greater risk of disability, hospitalization, social isolation, morbidity, and mortality, a hypothesis confirmed in the present study. The frail patients present a high mortality and an increase in the rate of admission and hospital stay.

Interestingly, perceived frailty by the patient or by nephrologist differs from the measured frailty using the Fried frailty phenotype scale and therefore is not accurate to assess frailty \[[@B26]\].

In our study, we found that frail patients compared to nonfrail patients present a higher hospitalization rate and a higher mortality, confirming the importance of having labelled patient as frail for a better clinical supervision.

It was described that in the general population frail older adults, regardless of their comorbidity and disability status, are at twice the risk of mortality and hospitalization \[[@B7]\].

Among dialysis population there is a lack of information regarding the association between frailty, hospitalization, and mortality, although the available results from the literature are indicating that frailty estimated using Fried scale is associated with higher mortality and hospitalization, independent of comorbidity and disability, in adults of all ages \[[@B6]\].

Several papers on frailty\'s possible causes have been published \[[@B27]--[@B29]\]. They can be summarized mainly in factors related to genetics, pathological antecedents, lifestyle, and aging.

In the present study, we performed a registry of the population with chronic kidney disease undergoing hemodialysis in our area. Applying a validated formula for frailty and adding a characteristic of the patient in dialysis---the need to increase dialysis time---we identify those indicators that contribute to or are predictors of frailty.

Although we think that the present work provides useful information on a topic as current in dialysis as frailty, evaluating a new scale of frailty, we admit that our work has limitations: it is an observational study, the frailty was not assessed prior to dialysis initiation, we use a criterion of frailty in which there is no international consensus, and the population sample is only 320 patients.

Therefore, we believe that efforts should be made to reach a common consensus on frailty in hemodialysis and that it is necessary to perform more studies with this consensus criteria and with a larger population sample.
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###### 

Clinical characteristics.

  -------------------- ---------------
  Age (years)          70,26 ± 13,85
  Gender (M)           59,4%
  BMI (kg/m2)          25,93 ± 5,18
  Hypertension         94,4%
  CVA                  85,9%
  IHD                  71,6%
  DM2                  39,7%
  COPD                 10,9%
  Liver disease        7,8%
  Dementia             4,1%
  Neoplastic disease   0,9%
  -------------------- ---------------

BMI: body mass index; CVA: cerebrovascular accident; IHD: ischemic heart disease; DM2: type 2 diabetes mellitus; COPD: chronic obstructive pulmonary disease; M: male.

###### 

Clinical and analytical characteristics of frail versus nonfrail patients.

  Variable   Frail (*n* = 18)   Nonfrail (*n* = 302)   *p*
  ---------- ------------------ ---------------------- -------
  Age        75,39 ± 11,53      69,85 ± 13,94          0,10
  BMI        22,53 ± 3,58       26,16 ± 5,18           0,004
  Hgb        10,35 ± 1,31       10,97 ± 1,18           0,032
  Albumin    3,61 ± 0,36        3,85 ± 0,29            0,001
  Npna       1,12 ± 0,26        10,01 ± 0,26           0,093
  CaxP       35,98 ± 10,58      38,34 ± 10,73          0,354
  *Ktv*      2,02 ± 0,23        1,88 ± 0,37            0,130

Npna: normalized protein nitrogen appearance; *Ktv*: *K*: urea clearance, *t*: dialysis time, and *V*: distribution volume.

###### 

Associated comorbidities of frail versus nonfrail patients.

  Variable     Frail (*n* = 18)   Nonfrail (*n* = 302)   *p*
  ------------ ------------------ ---------------------- ---------
  PV           38,8%              17,21%                 0,004
  CVD          16,6%              16,55%                 0,0079
  Depression   38,8%              12,58%                 0,004
  APBADL       33,33%             76,4%                  \<0,005
  Transfers    38,8%              84,7%                  \<0,005
  Karnofsky    44,4%              95,36%                 \<0,005

PV: peripheral vasculopathy; CVD: cerebrovascular disease; APBADL: ability to perform basic activities of daily living.

###### 

Vascular access of frail versus nonfrail patients.

  Vascular access   Nonfrail   Frail    *p*
  ----------------- ---------- -------- ---------
  Catheter          17,8%      61,6%    \<0,005
  Native FAVI       77,5%      27,78%   
  Prosthetic FAVI   5%         11,11%   
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